Home Nucleus Pharmaceuticals U.S. Influenza Drug Market to 2032

U.S. Influenza Drug Market to 2032

Overview

The U.S. Influenza Drug Market is expected to reach a 3.56 USD Billion by 2032 and is projected to grow at a CAGR of 11.53% from 2025 to 2032.

Revenue, 2024 (USD Billion)
1.78
Forecast, 2032 (USD Billion)
3.56
CAGR, 2024 - 2032
11.53%
Report Coverage
U.S.

U.S. Influenza Drug Market 2018-2032 USD Billion

U.S. Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 1.78 USD Billion
  • Projected Market Size (2032): 3.56 USD Billion
  • CAGR (2025-2032): 11.53%

Key Findings of U.S. Influenza Drug Market

  • The U.S. Influenza Drug Market was valued at 1.78 USD Billion in 2024.
  • The U.S. Influenza Drug Market is likely to grow at a CAGR of 11.53% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 3.12 USD Billion
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 12.13% during the forecast period from 2024 to 2032.

U.S. Influenza Drug Market Scope

U.S. Influenza Drug Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Homecare
  • Hospitals
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
Type
  • Influenza C
  • Influenza B
  • Influenza A

U.S. Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Billion
Market Value in 2024 1.78 USD Billion
Market Value in 2032 3.56 USD Billion
CAGR (2025-2032) 11.53%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Treatment,Route of Administration,Age,Type

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 1.78 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 1,779.64 USD Million in 2024.

Segments and Scope

  • U.S. Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 1.01 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 11.86 % in forecast period 2025-2032.
  • U.S. Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 1.28 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.
  • U.S. Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 3.12 USD Billion in the year 2024.
    • Vaccines is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 11.56 % in forecast period 2025-2032.
  • U.S. Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 883.42 USD Billion in the year 2024.
    • Oral is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 12.13 % in forecast period 2025-2032.
  • U.S. Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 911.72 USD Billion in the year 2024.
    • Pediatrics is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 11.98 % in forecast period 2025-2032.
  • U.S. Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in U.S. Influenza Drug Market to 2032 with a revenue of 849.83 USD Billion in the year 2024.
    • Influenza A is the Fastest growing segment in U.S. Influenza Drug Market to 2032 with a Growth rate of 12.04 % in forecast period 2025-2032.

U.S. Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
U.S. Influenza Drug Market Company Share Analysis

U.S. Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Influenza Drug Market Company Profiling

U.S. Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.S. Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
U.S. Influenza Drug Market was valued at USD 1.78(Revenue in USD Billion) in 2022.
U.S. Influenza Drug Market is projected to grow at a CAGR of 11.53% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the U.S. Influenza Drug Market, holding a largest market share of 3.12 USD Billion in 2024

U.S. Influenza Drug Market Scope

U.S. Influenza Drug Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Homecare
  • Hospitals
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
Type
  • Influenza C
  • Influenza B
  • Influenza A
Frequently Asked Questions
The U.S. Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
U.S. Influenza Drug Market was valued at USD 1.78(Revenue in USD Billion) in 2022.
U.S. Influenza Drug Market is projected to grow at a CAGR of 11.53% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Influenza Drug Market for final year is USD 3.56 (USD Billion).

U.S. Influenza Drug Market Company Profiling

U.S. Influenza Drug Market Company Profiling
Frequently Asked Questions
The U.S. Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
U.S. Influenza Drug Market was valued at USD 1.78(Revenue in USD Billion) in 2022.
U.S. Influenza Drug Market is projected to grow at a CAGR of 11.53% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Influenza Drug Market for final year is USD 3.56 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES